Research analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.10 on Tuesday. The company has a market cap of $114,000.00, a price-to-earnings ratio of -0.01 and a beta of 2.21. Ampio Pharmaceuticals has a fifty-two week low of $0.09 and a fifty-two week high of $8.30. The stock has a fifty day moving average price of $0.21 and a 200-day moving average price of $1.09.
About Ampio Pharmaceuticals
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- What is the Shanghai Stock Exchange Composite Index?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Manufacturing Stocks Investing
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.